This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Brosa M, Arocho R.Cost-effectiveness of the prevention of oral mucositis with Kepivance (Rm) (palifermin) in patients undergoing myeloablative therapy with autologous stem cell transplantation in Spain. Value in Health 9: A282 (plus poster) abstr. PCN22, No. 6, Nov-Dec 2006
Rights and permissions
About this article
Cite this article
Palifermin worth it for stomatitis prevention in Spain. Pharmacoecon. Outcomes News 518, 5 (2006). https://doi.org/10.2165/00151234-200605180-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605180-00015